What is IMRIS?
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions globally. The company's flagship offering, the VISIUS Surgical Theatre, is an advanced surgical environment that integrates intraoperative imaging modalities such as MRI, CT, and fluoroscopy directly into multi-purpose operating suites. This capability provides clinicians with real-time visual guidance, enhancing decision-making and precision for complex neurosurgical, spinal, cerebrovascular, and cardiovascular procedures. IMRIS serves hospitals worldwide, offering not only the surgical theatre systems but also comprehensive service, maintenance contracts, and accessories. Founded in 2005, the company has established itself as a key player in bringing cutting-edge imaging directly into the operating room.
How much funding has IMRIS raised?
IMRIS has raised a total of $67.4M across 2 funding rounds:
Stock Offering
$42.4M
Other Financing Round
$25M
Stock Issuance/Offering (2007): $42.4M, investors not publicly disclosed
Other Financing Round (2013): $25M led by Deerfield
Key Investors in IMRIS
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research.
What's next for IMRIS?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth trajectory for IMRIS. This capital infusion is likely to support the company's ongoing research and development efforts, potentially leading to enhancements in its VISIUS Surgical Theatre technology and the expansion of its product portfolio. Furthermore, the financing may enable IMRIS to broaden its market reach, both domestically and internationally, by strengthening its sales and distribution networks. The company's focus on integrating advanced imaging into surgical workflows positions it to capitalize on the increasing demand for minimally invasive and precision-driven medical interventions.
See full IMRIS company page
